United States · 
What does Monroe Capital invest in?
Monroe Capital invests most often at Debt and Venture (100% of the rounds on record).
Monroe Capital highlights
- 01
17 rounds on record
- 02
Mostly Debt and Venture: 100% of its rounds
- 03
Sole investor in 15 rounds, median $22M
- 04
1 exits from the portfolio
What they do
Filed 1 private fund offering with the SEC, the most recent in 2018-11From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Based in
- CHICAGO, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first17 appearances
- 2015
7 rounds
- Aug
- Aug
- Aug
- Jul
- May
- Apr
- Apr
- 2014
5 rounds
- Oct
- Aug
- Jul
- May
- Jan
- 2013
2 rounds
- Dec
- Jan
- 2011
3 rounds
- Sept
- Sept
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration24 named
ADAaron D. PeckChief Financial Officer and Corporate SecretaryiFiling they signed
ALAlex L. FrankyExecutive OfficeriFiling they signed
CLCarey L. DavidsonExecutive OfficeriFiling they signed
CLChristopher LundExecutive OfficeriFiling they signed
DDDavid D. EatonDirectoriFiling they signed
DHDavid H. JacobsonChief Compliance OfficeriFiling they signed
JMJames Mountz CassadyChief Operating OfficeriForm ADV
JCJeffrey CupplesExecutive OfficeriFiling they signed
JLJeremy L. VandermeidExecutive OfficeriFiling they signed
JOJeremy O'SullivanDirector of Monroe Capital Private Credit Fund II (Ireland) ICAV for the accountiFiling they signed
KSKarina StahlDirector of Monroe Capital Private Credit Fund II (Ireland) ICAV for the accountiFiling they signed
KRKristan Renee GregoryChief Compliance OfficeriForm ADV
KAKyle AsherExecutive OfficeriFiling they signed
LWLewis W. SolimeneChief Financial Officer, Chief Investment Officer and Corporate SecretaryiFiling they signed
MJMichael John EganVice Chairman and Chief Credit OfficeriForm ADV
PTPeter Toton GruszkaClass A Manager of the General Partner of the RAIF in respectiFiling they signed
RWRoger W. SchoenfeldDirectoriFiling they signed
RWRussel W. MironDirectoriFiling they signed
SAScott Andrew MarienauChief Financial OfficeriForm ADV
SLStefan L CorthoutsClass B Manager of the General Partner of the RAIF in respectiFiling they signed
TLTheodore Leon KoenigPresident and Chief Executive Officer of the Sole Member of the General Partner of the Issuer and Member of Investment CommitteeiFiling they signed
TCThomas Charles AronsonVice Chairman and Head of OriginationsiForm ADV
TDThomas David McKeeMember of the General PartneriFiling they signed
TEThomas EganExecutive OfficeriFiling they signed
We also hold 171 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$25Bassets it manages, 3 advisers combinedOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Monroe Capital Management Advisors LLC
- SEC number
- CRD 157073
Funds on its Form ADV
41 private funds, $16B in gross assets · filed Mar 2024
Private credit fund 26Securitised assets 15
- Monroe Capital Private Credit Master Fund IV SCSPPrivate credit fund358 investors$1.7B
- Monroe Private Credit Fund A, L.P.Private credit fund4 investors$1.7B
- Monroe Capital Private Credit Master Fund IV (Unleveraged) SCSPPrivate credit fund39 investors$1.4B
- Monroe Capital Private Credit Fund III L.P.Private credit fund272 investors$827M
- Monroe Capital Private Credit Versailles Master Fund SCSP SICAV-RAIFPrivate credit fund4 investors$636M
- Monroe Capital Private Credit Fund VT L.P.Private credit fund6 investors$509M
- Monroe Capital MML CLO XII, LTD.Securitised assets2 investors$494M
- Monroe Capital MML CLO XIV, LTD.Securitised assets3 investors$491M
- Monroe Capital MML CLO VIII, LTD.Securitised assets3 investors$473M
- Monroe Capital Opportunistic Private Credit Master Fund SCSPPrivate credit fund181 investors$473M
And 31 more on the filing.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Cytovance BiologicsBought by Hepalink$206MAug 2015
An exit counts when it came after the firm's first round in the company. From historical deal records.